LISBON, Portugal, August 30, 2010 A new internationalsurvey shows that over 90% of pharmacists believe they are key to improvingpatients' health, and while most pharmacists surveyed see theirresponsibilities increasing, they voice concerns on training and pay. Thesurvey shows that almost 3 in 4 pharmacists (73%) now provide patients withhealth promotion and management services. Nearly all (9 in 10) pharmacistsagree that more information and advice - including on specific medicationsand treatments - are expected from pharmacists than ever before. However mostpharmacists (78%) say that they are asked to provide additional services,such as advice, without fair and proper compensation.
"Pharmacists' roles are changing, and we find ourselves increasinglyworking with patients and other healthcare professionals to prevent and treatdisease. This survey shows that pharmacists welcome this expanded role, as ithighlights what they like doing most - helping deliver better patientoutcomes - while increasing visibility of pharmacists' expertise. However, wealso see an education and income gap that will need to be closed to ensurethe pressure on current pharmacists isn't too great, and so that we cancontinue to attract the best and brightest to the profession in the future,"said Ton Hoek, Chief Executive Officer of the International PharmaceuticalFederation (FIP).Other results of the survey show the degree to whichpharmacists are concerned about the counterfeit medicines issue.
Pfizer Inc. in collaboration with the International PharmaceuticalFederation (FIP) commissioned APCO Insight to conduct an international surveyto better understand the needs, concerns and attitudes of pharmacists.Interviews were held with over 2,000 community, retail and hospitalpharmacists in 8 countries (Australia, France, Germany, Italy, Portugal,Turkey, the UK and the U.S.) between April and June 2010.
"Clearly pharmacists and the pharmaceutical industry share some similarconcerns relative to patient's health. We both want to ensure thatpharmacists have the right knowledge and tools to educate patients abouttheir medicine as well as to ensure patients receive safe, effective andquality medicines, not counterfeit ones. Pfizer looks forward to continuingto support, through appropriate channels, pharmacist education programs thatwill ultimately translate into better outcomes for patients and healthcaresystems, globally", commented Dr. Emma Andrews, Director of External MedicalAffairs.
The International Pharmaceutical Federation (FIP) is the globalfederation of national associations of pharmacists and pharmaceuticalscientists in official relations with the World Health Organization (WHO),dedicated to improving the access to and value of appropriate medicine use,and contributing to changes in science, practice and health policiesworldwide. Through its 122 Member Organisations FIP represents and servesmore than two million pharmacists and scientists around the world.
About Pfizer, Inc.
Pfizer Inc: Working Together for a Healthier World(TM) At Pfizer, weapply science and our global resources to improve health and well-being atevery stage of life. We strive to set the standard for quality, safety andvalue in the discovery, development and manufacturing of medicines for peopleand animals. Our diversified global health care portfolio includes human andanimal biologic and small molecule medicines and vaccines, as well asnutritional products and many of the world's best-known consumer products.Every day, Pfizer colleagues work across developed and emerging markets toadvance wellness, prevention, treatments and cures that challenge the mostfeared diseases of our time. Consistent with our responsibility as theworld's leading biopharmaceutical company, we also collaborate with healthcare providers, governments and local communities to support and expandaccess to reliable, affordable health care around the world. For more than150 years, Pfizer has worked to make a difference for all who rely on us. Tolearn more about our commitments, please visit us at http://www.pfizer.com
About APCO Insight(R)
APCO Insight, a global opinion research and strategic communicationconsultancy, works with many of the world's leading companies, associations,nonprofits and public-sector organizations on a diverse range ofcommunication, reputation and issue management challenges.- A solid majority (61%) say the prevalence of counterfeit medication is a serious issue in their country. - A solid majority (63%) believe current policies and technology are insufficient to deal with counterfeit medicines - Most (77%) believe medicine packages should have machine readable bar codes to ensure they are not counterfeit
SOURCE FIP - International Pharmaceutical Federation